Arrow Mark Colorado Holdings LLC Cardiovascular Systems Inc Transaction History

Arrow Mark Colorado Holdings LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $897,456 - $1.07 Million	70,444 Added 10.5%	741,523 $10.1 Million
Q3 2022 Nov 14, 2022	SELL	$12.93 - $17.17 $272,629 - $362,029	-21,085 Reduced 3.05%	671,079 $9.3 Million
Q2 2022 Aug 15, 2022	SELL	$13.53 - $23.34 $872,427 - $1.5 Million	-64,481 Reduced 8.52%	692,164 $9.94 Million
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $709,256 - $993,134	43,944 Added 6.17%	756,645 $17.1 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $3.45 Million - $6.82 Million	185,343 Added 35.15%	712,701 $13.4 Million
Q3 2021 Nov 15, 2021	SELL	$32.83 - $43.0 $423,178 - $554,270	-12,890 Reduced 2.39%	527,358 $17.3 Million
Q2 2021 Aug 16, 2021	SELL	$34.41 - $44.03 $23,777 - $30,424	-691 Reduced 0.13%	540,248 $23 Million
Q1 2021 May 17, 2021	BUY	$37.29 - $47.19 $332,775 - $421,123	8,924 Added 1.68%	540,939 $20.7 Million
Q4 2020 Feb 16, 2021	SELL	$34.3 - $44.09 $692,791 - $890,529	-20,198 Reduced 3.66%	532,015 $23.3 Million
Q3 2020 Nov 16, 2020	SELL	$27.86 - $39.35 $1.3 Million - $1.84 Million	-46,727 Reduced 7.8%	552,213 $21.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.3 - $42.55 $18.1 Million - $25.5 Million	598,940 New	598,940 $18.9 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.